13F filing recap · Q2 2017

What did Davis Advisors buy in Q2 2017?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Davis account, including accounts that belong to no fund below.

Stock value

$22.85B

Positions

142

Estimated turnover

12.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

YAlleghany Corporation$46.38Mreported value+78.0K shares VSAVisionsys AI Inc.$14.21Mreported value+793.5K shares CXOConcho Resources Inc.$6.61Mreported value+54.4K shares DOWDow Inc.$871.0Kreported value+13.8K shares DXCDxc Technology Co$473.0Kreported value+6.2K shares

Increased positions

WFCWells Fargo & Company/mn$1.44Breported value+472.6K shares+1.9%COFCapital One Financial Corp$666.08Mreported value+4.27M shares+112.8%FDXFedex Corporation$366.12Mreported value+1.22M shares+265.4%BRK.BBerkshire Hathaway Inc$284.19Mreported value+5.8K shares

Reduced positions

AMZNAmazon.com Inc$1.50Breported value-177.5K shares-10.3%JPMJPMorgan Chase & Co$1.23Breported value-1.77M shares-11.6%GOOGAlphabet Inc.$1.08Breported value-59.9K shares-4.8%BRK.ABerkshire Hathaway Inc$1.07Breported value-78 shares

Exited positions

VRXValeant Pharmaceuticals International, Inc.$43.21Mprior reported value-3.92M shares-100.0%MBLYMobileye NV$35.22Mprior reported value-573.6K shares-100.0%DFTDupont Fabros Technology, Inc.$8.37Mprior reported value-168.8K shares-100.0%NYRTNew York Reit, Inc.$6.16Mprior reported value